{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T11:15:19Z","timestamp":1787483719998,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001869","name":"academia sinica","doi-asserted-by":"publisher","award":["AS-GMM-110-01"],"award-info":[{"award-number":["AS-GMM-110-01"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>Glycogen storage disease type I (GSD-I) is an autosomal recessive disorder of carbohydrate metabolism, resulting in limited production of glucose and excessive glycogen storage in the liver and kidneys. These patients are characterized by life-threatening hypoglycemia, metabolic derangements, hepatomegaly, chronic kidney disease, and failure to thrive. Liver transplantation (LT) has been performed for poor metabolic control and delayed growth. However, renal outcome was diverse in pediatric GSD patients after LT. The aim of this study was to investigate the long-term outcome of renal function in pediatric GSD-I patients after living donor LT (LDLT), and to identify modifiable variables that potentially permits LT to confer native renal preservation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included eight GSD-Ia and one GSD-Ib children with a median age of 9.0 (range 4.2\u201315.7) years at the time of LT. Using propensity score matching, 20 children with biliary atresia (BA) receiving LT were selected as the control group by matching for age, sex, pre-operative serum creatinine (SCr) and pediatric end-stage liver disease (PELD) score. Renal function was evaluated based on the SCr, estimated glomerular filtration rate (eGFR), microalbuminuria, and morphological changes in the kidneys. Comparability in long-term renal outcome in terms of anatomic and functional parameters will help to identify pre-LT factors of GSD-I that affect renal prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The clinical and biochemical characteristics of the GSD and BA groups were similar, including immunosuppressive regimens and duration of follow-up (median 15\u00a0years) after LT. Overall, renal function, including eGFR and microalbuminuria was comparable in the GSD-I and BA groups (median eGFR: 111 vs. 123\u00a0ml\/min\/1.73m<jats:sup>2<\/jats:sup>, <jats:italic>P<\/jats:italic>\u2009=\u20090.268; median urine microalbuminuria to creatinine ratio: 16.0 vs. 7.2\u00a0mg\/g, <jats:italic>P<\/jats:italic>\u2009=\u20090.099, respectively) after LT. However, in the subgroups of the GSD cohort, patients starting cornstarch therapy at an older age (\u2265\u20096-year-old) before transplantation demonstrated a worse renal outcome in terms of eGFR change over years (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In addition, the enlarged kidney in GSD-I returned to within normal range after LT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Post-LT renal function was well-preserved in most GSD-I patients. Early initiation of cornstarch therapy before preschool age, followed by LT, achieved a good renal prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02026-6","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T18:19:25Z","timestamp":1633976365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Yi-Chia","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0566-9312","authenticated-orcid":false,"given":"Chao-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldwin D.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Che","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee-Chien","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Suei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Yuarn","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"issue":"2","key":"2026_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s0950-3528(98)90138-5","volume":"12","author":"A Burchell","year":"1998","unstructured":"Burchell A. Glycogen storage diseases and the liver. Baillieres Clin Gastroenterol. 1998;12(2):337\u201354. https:\/\/doi.org\/10.1016\/s0950-3528(98)90138-5.","journal-title":"Baillieres Clin Gastroenterol"},{"issue":"1","key":"2026_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1056\/nejm198801073180102","volume":"318","author":"YT Chen","year":"1988","unstructured":"Chen YT, et al. Renal disease in type I glycogen storage disease. N Engl J Med. 1988;318(1):7\u201311. https:\/\/doi.org\/10.1056\/nejm198801073180102.","journal-title":"N Engl J Med"},{"issue":"5133","key":"2026_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.8211187","volume":"262","author":"KJ Lei","year":"1993","unstructured":"Lei KJ, et al. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science. 1993;262(5133):580\u20133. https:\/\/doi.org\/10.1126\/science.8211187.","journal-title":"Science"},{"issue":"11","key":"2026_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16(11): e1. https:\/\/doi.org\/10.1038\/gim.2014.128.","journal-title":"Genet Med"},{"issue":"3","key":"2026_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10545-014-9761-0","volume":"38","author":"F Rajas","year":"2015","unstructured":"Rajas F, et al. Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease. J Inherit Metab Dis. 2015;38(3):521\u20137. https:\/\/doi.org\/10.1007\/s10545-014-9761-0.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2026_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1023\/a:1005346824368","volume":"20","author":"JI Wolfsdorf","year":"1997","unstructured":"Wolfsdorf JI, Laffel LM, Crigler JF Jr. Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis. 1997;20(4):559\u201368. https:\/\/doi.org\/10.1023\/a:1005346824368.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2026_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jhep.2009.05.026","volume":"51","author":"SK Reddy","year":"2009","unstructured":"Reddy SK, et al. Liver transplantation for glycogen storage disease type Ia. J Hepatol. 2009;51(3):483\u201390. https:\/\/doi.org\/10.1016\/j.jhep.2009.05.026.","journal-title":"J Hepatol"},{"issue":"7","key":"2026_CR8","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","volume":"12","author":"PS Kishnani","year":"2010","unstructured":"Kishnani PS, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010;12(7):446\u201363. https:\/\/doi.org\/10.1097\/GIM.0b013e3181e655b6.","journal-title":"Genet Med"},{"issue":"4","key":"2026_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/MCO.0000000000000181","volume":"18","author":"P Burda","year":"2015","unstructured":"Burda P, Hochuli M. Hepatic glycogen storage disorders: what have we learned in recent years? Curr Opin Clin Nutr Metab Care. 2015;18(4):415\u201321. https:\/\/doi.org\/10.1097\/MCO.0000000000000181.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"2026_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/pedi.12540","volume":"18","author":"M Dambska","year":"2017","unstructured":"Dambska M, et al. Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control. Pediatr Diabetes. 2017;18(5):327\u201331. https:\/\/doi.org\/10.1111\/pedi.12540.","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"2026_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jhep.2012.09.030","volume":"58","author":"J Calderaro","year":"2013","unstructured":"Calderaro J, et al. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2013;58(2):350\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2012.09.030.","journal-title":"J Hepatol"},{"issue":"Suppl 2","key":"2026_CR12","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/pl00014320","volume":"158","author":"D Matern","year":"1999","unstructured":"Matern D, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr. 1999;158(Suppl 2):S43\u20138. https:\/\/doi.org\/10.1007\/pl00014320.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"2026_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/lt.21151","volume":"13","author":"SG Iyer","year":"2007","unstructured":"Iyer SG, et al. Long-term results of living donor liver transplantation for glycogen storage disorders in children. Liver Transpl. 2007;13(6):848\u201352. https:\/\/doi.org\/10.1002\/lt.21151.","journal-title":"Liver Transpl"},{"issue":"1","key":"2026_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/lt.25649","volume":"26","author":"S Shimizu","year":"2020","unstructured":"Shimizu S, et al. Longterm outcomes of living donor liver transplantation for glycogen storage disease type 1b. Liver Transpl. 2020;26(1):57\u201367. https:\/\/doi.org\/10.1002\/lt.25649.","journal-title":"Liver Transpl"},{"key":"2026_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1172-9-47","volume":"9","author":"SJ Boers","year":"2014","unstructured":"Boers SJ, et al. Liver transplantation in glycogen storage disease type I. Orphanet J Rare Dis. 2014;9:47. https:\/\/doi.org\/10.1186\/1750-1172-9-47.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2026_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1681\/ASN.V451159","volume":"4","author":"AS Levey","year":"1993","unstructured":"Levey AS, et al. Glomerular filtration rate measurements in clinical trials. Modification of diet in renal disease study group and the diabetes control and complications trial research group. J Am Soc Nephrol. 1993;4(5):1159\u201371.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2026_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/asn.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629\u201337. https:\/\/doi.org\/10.1681\/asn.2008030287.","journal-title":"J Am Soc Nephrol"},{"issue":"s11","key":"2026_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1524-6175.2004.4064.x","volume":"6","author":"RD Toto","year":"2004","unstructured":"Toto RD. Microalbuminuria: Definition, Detection, and Clinical Significance. J Clin Hypertens. 2004;6(s11):2\u20137. https:\/\/doi.org\/10.1111\/j.1524-6175.2004.4064.x.","journal-title":"J Clin Hypertens"},{"key":"2026_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"KDIGO CKD Work Group","year":"2013","unstructured":"KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"2026_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00134-014-3391-8","volume":"40","author":"DT Selewski","year":"2014","unstructured":"Selewski DT, et al. Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population. Intensive Care Med. 2014;40(10):1481\u20138. https:\/\/doi.org\/10.1007\/s00134-014-3391-8.","journal-title":"Intensive Care Med"},{"key":"2026_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030372","author":"C Thongprayoon","year":"2019","unstructured":"Thongprayoon C, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8030372.","journal-title":"J Clin Med"},{"issue":"11","key":"2026_CR22","doi-asserted-by":"publisher","first-page":"e0224785","DOI":"10.1371\/journal.pone.0224785","volume":"14","author":"HA Su","year":"2019","unstructured":"Su HA, et al. Reference ranges for ultrasonographic renal dimensions as functions of age and body indices: a retrospective observational study in Taiwan. PLOS ONE. 2019;14(11):e0224785. https:\/\/doi.org\/10.1371\/journal.pone.0224785.","journal-title":"PLOS ONE"},{"issue":"3","key":"2026_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2214\/ajr.142.3.467","volume":"142","author":"DM Rosenbaum","year":"1984","unstructured":"Rosenbaum DM, Korngold E, Teele RL. Sonographic assessment of renal length in normal children. AJR Am J Roentgenol. 1984;142(3):467\u20139. https:\/\/doi.org\/10.2214\/ajr.142.3.467.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2026_CR24","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1007\/bf02072091","volume":"152","author":"WC Reitsma-Bierens","year":"1993","unstructured":"Reitsma-Bierens WC. Renal complications in glycogen storage disease type I. Eur J Pediatr. 1993;152(1):S60\u20132. https:\/\/doi.org\/10.1007\/bf02072091.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"2026_CR25","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1007\/s00431-002-1000-2","volume":"161","author":"DA Weinstein","year":"2002","unstructured":"Weinstein DA, Wolfsdorf JI. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr. 2002;161(1):S35\u20139. https:\/\/doi.org\/10.1007\/s00431-002-1000-2.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"2026_CR26","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ki.1989.133","volume":"35","author":"L Baker","year":"1989","unstructured":"Baker L, et al. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int. 1989;35(6):1345\u201350. https:\/\/doi.org\/10.1038\/ki.1989.133.","journal-title":"Kidney Int"},{"issue":"1","key":"2026_CR27","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/s00431-002-0999-4","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002;161(1):S20\u201334. https:\/\/doi.org\/10.1007\/s00431-002-0999-4.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2026_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00467-018-4128-7","volume":"35","author":"AM Uber","year":"2020","unstructured":"Uber AM, Sutherland SM. Acute kidney injury in hospitalized children: consequences and outcomes. Pediatr Nephrol. 2020;35(2):213\u201320. https:\/\/doi.org\/10.1007\/s00467-018-4128-7.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2026_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1053\/j.ackd.2017.09.007","volume":"24","author":"SM Sutherland","year":"2017","unstructured":"Sutherland SM, Kwiatkowski DM. Acute kidney injury in children. Adv Chronic Kidney Dis. 2017;24(6):380\u20137. https:\/\/doi.org\/10.1053\/j.ackd.2017.09.007.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-019-0214-y","author":"TA Lawal","year":"2019","unstructured":"Lawal TA, et al. Predictors and outcome of acute kidney injury after non-cardiac paediatric surgery. Renal Replacement Therapy. 2019. https:\/\/doi.org\/10.1186\/s41100-019-0214-y.","journal-title":"Renal Replacement Therapy"},{"issue":"4","key":"2026_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00007890-200108270-00012","volume":"72","author":"UB Berg","year":"2001","unstructured":"Berg UB, Ericzon BG, Nemeth A. Renal function before and long after liver transplantation in children. Transplantation. 2001;72(4):631\u20137. https:\/\/doi.org\/10.1097\/00007890-200108270-00012.","journal-title":"Transplantation"},{"issue":"2","key":"2026_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1399-3046.2003.00132.x","volume":"8","author":"N Arora-Gupta","year":"2004","unstructured":"Arora-Gupta N, et al. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant. 2004;8(2):145\u201350. https:\/\/doi.org\/10.1046\/j.1399-3046.2003.00132.x.","journal-title":"Pediatr Transplant"},{"issue":"2","key":"2026_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1399-3046.2007.00803.x","volume":"12","author":"MK Davis","year":"2008","unstructured":"Davis MK, Weinstein DA. Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk\/benefit of this procedure. Pediatr Transplant. 2008;12(2):137\u201345. https:\/\/doi.org\/10.1111\/j.1399-3046.2007.00803.x.","journal-title":"Pediatr Transplant"},{"issue":"25","key":"2026_CR34","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1093\/hmg\/11.25.3199","volume":"11","author":"LY Chen","year":"2002","unstructured":"Chen LY, et al. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib. Hum Mol Genet. 2002;11(25):3199\u2013207. https:\/\/doi.org\/10.1093\/hmg\/11.25.3199.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2026_CR35","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1089\/hum.2019.102","volume":"30","author":"L Jauze","year":"2019","unstructured":"Jauze L, et al. Challenges of gene therapy for the treatment of glycogen storage diseases type I and type III. Hum Gene Ther. 2019;30(10):1263\u201373. https:\/\/doi.org\/10.1089\/hum.2019.102.","journal-title":"Hum Gene Ther"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02026-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T18:32:52Z","timestamp":1633977172000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2026"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02026-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"27 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human Research Ethics Committee approval was granted for the collection and analysis of the data (Chang Gung Medical Foundation Institutional Review Board, IRB no. 201800281B0C101). Informed consent was waived because of the retrospective nature of the study and our Human Research Ethics Committee also approved the informed consent waiver. All the study protocol was in accordance with Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflicts of interests exist.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"423"}}